Commercial Sales and Distribution Agreement with CBDS Health
Filed with ASX · · 2 pages · English
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- First production completed for strong vape segment growth
- LSH Acquires Seng Vital for Cannabis Opportunities
- Lifespot Strengthens Go-To-Market Cannabis Strategy
- Update on Unique Cannabis Vaporiser launch and Bodytel
- LSH in discussions to finance integrated cannabis producers
Later from Nexalis Therapeutics
- Amended - Appendix 4C September 2018 Quarter
- Business Development focus in rapid growth Cannabis Category
- Lifespot signs Heads of agreement with IONIC brands
- Production of new slim line Smart Vaporiser for usa
- Private Placement Successfully Completed to raise $330,000
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics